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1. Introduction
People with Down syndrome are prone to early ageing and Alzheimer’s disease (Zigman &
Lott 2007). The functional decline in adults with Down syndrome starts decades earlier,
compared to the mainstream population and other people with intellectual disabilities
(Zigman et al. 1996; Strydom et al. 2007). The coping skills necessary for daily life, social
interactions and work are gradually lost during the progression of dementia (Margallo-Lana
et al. 2007).
Typical neuropathology of Alzheimer’s disease is seen in virtually all people with Down
syndrome by the age of 40 (Wisniewski et al. 1985). Depending on diagnostic criteria, 17-55%
of them develop clinical dementia after that age (Holland et al. 2000; Janicki & Dalton 2000;
Coppus et al. 2006). Genetic factors modifying the risk of dementia in adults with Down
syndrome have been identified (Zigman & Lott 2007; Prasher et al. 2008; Patel et al. 2010). The
rates of dementia in adults with intellectual disability without Down syndrome aged 60 years
and older are greater than expected (Strydom et al. 2007).
The cognitive impairment in adults with Down syndrome has similarities to early cognitive
changes in Alzheimer's disease (Brugge et al.1994). Personality and behaviour changes (Ball et
al. 2006), executive dysfunction (Ball et al. 2008) and selective attention deficits (Krinsky-
McHale et al. 2008) are early signs of dementia in adults with Down syndrome. Frontal-like
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dementia can be diagnosed in 33% in their thirties (Holland et al. 2000). Maladaptive behaviour
is often seen and includes aggression, fearfulness, sadness, sleep problems, social inadequacy,
stealing and general regressive behaviour (Urv et al. 2008). Increasing age associates with
decreasing cognitive and language abilities; the deterioration with the age is largely explained
by the presence of Alzheimer’s disease (Iacono et al. 2010).
Identification of persons with risk of early dementia remains a challenge (Shulz et al. 2004).
Direct assessments of cognitive functions of people with intellectual disabilities may be
difficult (Pyo et al. 2007). Informant-based assessments are useful as complementary or
alternative methods in clinical work (Ball et al. 2004; Prasher et al. 2004; Niuwenhuis-Mark
2009).
The Adaptive Behavior Scale - Residential and Community (Nihira et al. 1993) and its earlier
versions have been widely used in research. Cross-sectional studies have demonstrated lower
scores on people with Down syndrome older than 40 years compared to younger participants
with Down syndrome (Collacott 1992). The age-related decline of adaptive behaviour asso‐
ciates to dementia (Prasher & Chung 1996). Prospective studies have confirmed changes in
adaptive behaviour (Rasmussen & Sobsey 1994; Prasher et al. 1998). Zigman et al. (2002)
described the incidence and temporal patterns of adaptive behaviour changes in adults with
intellectual disabilities. Rasmussen and Sobsey (1994) found stability of adaptive behaviour in
adults with Down syndrome in the age groups younger than 40 years and a pattern of decline
in self-help and communication skills in several individuals with Down syndrome older than
40, including declines in dressing, receptive language, vocational and domestic behaviour.
Relative preservation of cognitive and functional ability in persons with Down syndrome older
than 45 associates with better survival whereas clinically, the most important disorders that
are related to mortality are dementia, mobility restrictions, visual impairment, and epilepsy
(Coppus et al. 2008).
Health co-morbidities in ageing persons with Down syndrome and Alzheimer's dementia are
common (McCarron et al. 2005). Depression often precedes the onset of dementia in people
with Down syndrome (Burt et al. 1992). Visual impairment and hearing loss are very common
in elderly people with Down syndrome (van Splunder et al. 2006; Meuwese-Jongejeugd et al.
2006; Meuwese-Jongejeugd et al. 2008). Epilepsy is often seen at the same age with dementia
(Collacott 1993). Hypothyroidism may also affect adaptive behaviour (Bhaumik et al. 1991).
The absence of a medical illness predicts a higher level of adaptive behaviour, while dementia
is a predictive factor for increased maladaptive behaviour (Prasher & Chung 1996) and
psychiatric symptoms (Urv et al. 2010)
Medication for Alzheimer’s disease might benefit many people with Down syndrome by
slowing the progression of the disease (Prasher et al. 2002). Accurate measures are important
for the follow-up and evaluation of treatments. It is necessary to find and use valid, reliable
and sensitive methods for assessments of adults and ageing people with Down syndrome and
Alzheimer’s disease.
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The aim of the present study was to explore the clinical usefulness of repeated assessments of
adaptive behaviour in people with Down syndrome and suspected or confirmed dementia.
Repeated assessments of adaptive behaviour in people at risk of functional decline might help
to confirm the change and lead to necessary additional evaluations of the underlying reasons
and help in follow-up.
2. Methods
Study population
The participating adults with Down syndrome were recruited to the study at a specialized
service centre for people with intellectual disabilities serving a population of 79 690 (December
2008), among them 723 people with identified intellectual disability. These include 84 people
with Down syndrome; 19 of them were 0-19 years old, 65 were 20 years old or older. Forty of
the 65 adults belonged to the age group 40 years old or older.
Assessments of adaptive behaviour were conducted to 42 persons with Down syndrome (Table
1). Twenty five persons had repeated assessments. These persons’ proxies had noticed a change
of mood, behaviour or performance. At the time of the first evaluation, their age range was
24-61 years, with a mean of 45.8 and SD of +/- 8.4; at the time of the last evaluation, the
corresponding figures were 25-65.5, 48.8, and +/- 8.4 years, respectively. The mean time of
follow-up was, thus, 3.0 years (range 0-8 years). Five participants died during the follow up.
Twenty participants (80%) of the 25 were 40 years or older at the time of the first evaluation.
Most participants (17/25, 68%) resided at the beginning of the follow-up in small group homes,
seven (28%) at home with parents or siblings and one in institution. Fourteen participants (56%)
had organized weekly activities outside the home and two participants had part time sup‐
ported work.
Methods
Repeated informant evaluations regarding observed changes in behaviour were recorded
prospectively. Evaluations of adults with Down syndrome were performed over ten years,
beginning in 2001. Adaptive behaviour assessments were performed by the closest relatives
or carers who lived or worked with the participants and knew the persons and their daily skills
for a long time.
The current coping skills for daily living were assessed using the Adaptive Behavior Scale -
Residential and Community, ABS-RC: 2 1993, Part I (Nihira et al. 1993). The Adaptive Behavior
Scale (ABS) was chosen because the reliability and validity of this method are well established.
Earlier research supports its feasibility in the use of scientific studies of ageing and dementia
in people with intellectual disabilities (Rasmussen & Sobsey 1994; Prasher et al. 1998; Zigman
et al. 2002).
The first part of ABS is focused on personal independence and includes ten domains or
subscales: Independent Functioning, Physical Development, Economic Activity, Language
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Development, Numbers and Time, Domestic Activity, Prevocational/Vocational Activity, Self-
Direction, Responsibility and Socialization. The ABS Manual reports that factor analysis has
found three Part One factors: Personal Self-Sufficiency, Community Self-Sufficiency, and
Personal–Social Responsibility.
Clinical evaluations were done by the principal investigator. These included interviews of the
proxies, referrals for differential diagnostics and specialist consultations, and prescriptions
and assessments of medications. Additional clinical data was drawn from the case records of
the health centres, central hospital and service centre regarding all persons with Down
syndrome in the region. The data of medical treatments for Alzheimer’s disease, depression,
behavioural problems, epilepsy, and other major health concerns possibly affecting adaptive
behaviour were analyzed. The age at the time of the first observation of functional decline was
calculated.
Informant ratings by ABS were scored and analysed. Total scores, scores for the ten subscales
and three factors of ABS and changes of scores from the first to the last evaluation were counted.
The ABS score changes as percentages per three years were calculated for subgroups of
participants with and without Alzheimer’s disease, depression, epilepsy, hypothyroidism, and
antipsychotic medication use for challenging behaviour.
The ethical committee of the Kainuu Central Hospital approved the study and permission for
combining data from medical and social records was given by the Ministry of Social and Health
Affairs.
3. Results
The number of people with Down syndrome living in the area is well known and their
morbidity data was available for comparison. The participants with repeated ABS assessments
were older than participants with single assessments. Dementia, medication use for challeng‐
ing behaviour, depression and epilepsy were more common among participants than among
adults with Down syndrome living in the region.
Alzheimer’s disease
Alzheimer’s disease with dementia was diagnosed in 15 out of the 25 participants assessed
repeatedly. Four of them died during the survey. The diagnosis was confirmed in ten partic‐
ipants by a neurologist and in five participants by the first author with competence in intel‐
lectual disability medicine. Other causes of dementia were excluded. Computerized
tomographies of the brain were performed in ten of these participants. Eleven persons received
medication for Alzheimer’s disease (donepezile, galantamine or rivastigmine, in three
participants combined with memantine). Early dementia was suspected in an additional four
participants; they had increasing difficulties following instructions and performing their usual
domestic work.
The number of living people with diagnosed and suspected dementia (fifteen persons among
the participants and two not participating in this study) among adults with Down syndrome
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in the region gives prevalence’s of dementia 38% (15 of 40 persons) in the age group 40 years
and more, and 13% (two of 15 persons) in the age group 30-39 years. The prevalence estimate
of dementia for the age group 30 years and more is thus 31% (17 of 55 persons).
Medical problems
Of the 25 participants eleven (44%) had experienced long periods of depression. Thirteen (52%)
had received antipsychotic medication mainly for behavioural problems, six of them already
during early adulthood and eight for behavioural problems with dementia. Eleven persons
were treated for hypothyroidism. Varying degrees of visual impairment were common, and
three had cataracts. Recurrent faints were seen in eight, with falls causing fractures in three
persons. Epilepsy was diagnosed in eight persons.
Among participants with Alzheimer’s disease (n=15), antipsychotic medication had been used
for eleven (73%), depression had been diagnosed in ten (67%), thyroid disease in ten (67%),
and epilepsy in seven (47%) participants. Among participants without Alzheimer’s disease
(n=10), antipsychotic medication had been used for two (20%), depression had been diagnosed
in one (10%), thyroid disease in four (40%), and epilepsy in one participant (10%). Among
eleven participants with depression (N=11), antipsychotic medication had been used for seven
(64%), Alzheimer’s disease had been diagnosed in ten (91%), thyroid disease in 6 (55%), and
epilepsy in five (45%) participants.
Informant observations
A decline of daily functioning was observed by informants in regards to 19 of 25 persons,
starting at the ages of 37-51 years with a mean of 44.9 and SD +/- 4 years in persons with full
trisomy of chromosome 21. In addition, there was one participant with mosaic trisomy of
chromosome 21 whose decline started only at the age of 60 (Figure 3, participant 2).
Adaptive Behavior Scale (ABS) scores
The mean ages, ABS total scores at first and last assessments and the calculated percentages
of score changes per three years in subgroups of participants are presented in Table 1. The
mean ABS total scores for the 25 participants with multiple assessments declined from 161 to
126 (21.8%) during the mean 3.0 years between the first and last assessments. The decline of
ABS total scores associated very strongly to Alzheimer’s disease: there was no decline in the
mean ABS total scores in the group of participants with no suspected or confirmed Alzheimer’s
disease. The mean rates of ABS score change were higher in participant groups with Alzheim‐
er’s disease (33.6% in three years), and depression (32.0%) compared to participants without
these conditions (0.6% and 13.9% respectively). The participants treated with medication for
Alzheimer’s disease had lower mean rates of score declines compared to untreated patients,
31% and 40% declines in three years respectively. The mean rates of change were almost similar
in groups of persons with and without epilepsy, antipsychotic medication, and hypothyroid‐
ism. (Table 1)
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Participants (number of persons) Age of participants atfirst (last) assessment
ABS total scores, means
at first (last) assessment
ABS score change
percentage per three
years, %
Participants with single assessments (17) 36.5 (36.5) 174 (174)
males (10) 32.3 (32.3) 188 (188)
females (7) 42.4 (42.4) 155 (155)
Participants with repeated assessments
(25)
45.8 (48.8) 161 (126)
-21.8
males (11) 43.8 (47.0) 135 (117) -12.4
females (14) 48.4 (51.5) 193 (137) -28.4
Alzheimer`s disease (AD, 15) 49.7 (52.9) 165 (106) -33.6
AD, no medication (4) 47.8 (50.8) 155 (93) -40.0
AD, medication (11) 50.6 (53.9) 170 (112) -31.0
No AD (10) 40.0 (43.1) 154 (155) +0.6
Depression (11) 47.6 (50.5) 159 (112) -32.0
No depression (14) 44.4 (47.8) 162 (136) -13.9
Epilepsy (8) 50.6 (54.5) 193 (141) -23.0
No epilepsy (17) 43.5 (46.5) 145 (118) -18.7
Antipsychotic medication (13) 49.0 (52.0) 168 (132) -21.7
No antipsychotic medication (12) 42.3 (45.7) 152 (119) -19.3
Hypothyroidism (11) 45.8 (48.7) 152 (125) -19.4
No hypothyroidism (14) 45.8 (49.1) 166 (126) -21.5
Table 1. Ages, ABS-RC:2 total scores and score changes in subgroups of participants with Down syndrome.
ABS-RC:2 subscale Scores, first assessmentMean (SD)
Scores, last assessment
Mean (SD) Score change, %
Domestic Activity 9.6 (6.1) 5.8 (6.1) -64.8
Responsibility 5.0 (3.0) 3.3 (3.1) -51.2
Self-Direction 12.1 (5.9) 8.0 (6.9) -50.3
Prevocational/Vocational Activity 5.8 (3.1) 4.0 (3.6) -44.0
Numbers and Time 5.4 (3.4) 3.8 (3.8) -41.1
Independent Functioning 64.8 (24.3) 52.3 (32.0) -23.8
Language Development 21.0 (9.4) 17.2 (8.9) -22.0
Economic Activity 3.6 (3.3) 3.2 (3.5) -12.5
Physical Development 18.4 (3.5) 16.0 (5.5) -15.0
Economic Activity 3.6 (3.3) 3.2 (3.5) -12.5
Table 2. ABS-RC:2 subscale mean scores and their change during the prospective follow-up of 25 participants with
Down syndrome.
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The biggest mean declines were seen in the subscales Domestic Activity, Responsibility and
Self-Direction, to 35.2, 48.8 and 49.7%, respectively. The slightest changes were seen in the
domains of Economic Activity, Physical Development and Language Development (Table 2).
The mean changes of scores for the ABS factors Personal Self-Sufficiency, Community Self-
Sufficiency and Personal–Social Responsibility were 22.2, 27.9 and 36.8%, respectively.
Individual changes in ABS scores
The ABS scores remained stable in nine and improved in three persons. A progressive decline
of ABS scores was seen in 13 of 25 (52%) participants after their early forties. The direction,
amount and rate of change of ABS scores varied from an increase of 27% within a year in the
youngest participant recovering from deep depression to 90% decline during seven years in
an ageing participant.
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Figure 1. Adaptive behaviour in 9 participants without clinical Alzheimer’s disease
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Figure 2. Adaptive behaviour in 12 participants with diagnosed Alzheimer’s disease
Adaptive Behaviour Change and Health in Adults with Down Syndrome: A Prospective Clinical Follow-Up Study
http://dx.doi.org/10.5772/57461
319
050
100
150
200
250
300
45 50 55 60 65
Age, years
A
B
S-
R
C:
2 
pa
rt
 
1 
s
c
o
re
s
Figure 3. Adaptive behaviour in two participants with different clinical course of diagnosed Alzheimer’s disease: par‐
ticipant 1 with slow progression of dementia (clinical case data given in text), participant 2 with mosaic trisomy of
chromosome 21 and late onset of dementia
4. Late onset of dementia with mosaic trisomy of chromosome 21
For most of the younger and many of older participants too, changes in ABS scores were
minimal (Figure 1). Slight improvement in scores at ages 38-40 was seen in an participant after
a change of residence, coupled with increasing exercise, weight loss and improved fitness. The
highest scores with slight improvement at ages 38-43 were seen in a participant in spite of
many treated health problems, including a slight permanent visual impairment, hypothyr‐
oidism, fractures associated with osteoporosis and bronchial asthma.
The ABS scores declined in most participants with Alzheimer´s disease (Figure 2). Improve‐
ments in ABS scores were seen in two elderly participants. In the first participant (Figure 2),
the improvement at age 42 to 43 associated to the change of residence and medical treatment
of Alzheimer’s disease with response for two years before advancing deterioration later.
Epilepsy and loss of mobility after a fall resulting in a hip fracture, and poor visual acuity
contributed to the loss of independent functioning.
The improvement of the other participant (Figure 3) during the treatment of confirmed
Alzheimer’s disease, after a decline at age 48 to 49 lasted five years before further deterioration.
Contributing factors to the functional improvement were the removal of cataracts resulting in
improved visual acuity, active participation in activities with support of the carers, and
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stabilization of mood and behaviour. This participant had a long history of hypothyroidism,
depression and challenging behaviour and he had long-term antidepressant and antipsychotic
medication, and successful treatment of late onset epilepsy.
5. Discussion
We report experiences of a long term prospective clinical follow-up of adults with Down
syndrome. The participants in this study were adults with Down syndrome and behavioural
changes as perceived by carers. Adults without behavioural or mood changes observed by
their proxies were not actively recruited and thus this group is not represented in this survey.
The participants represent adults with Down syndrome with observed change of mood,
behaviour or performance causing concern in their proxies.
Depression and, among participants in their forties and older, Alzheimer’s dementia were the
most common underlying reasons for the behavioural change. The number of participants with
diagnosed and suspected dementia gave estimates of prevalence comparable to published
epidemiological studies. Most people with Down syndrome and diagnosed Alzheimer’s
dementia in this population participated in this study. A change of behaviour or adjustment
had been noticed by their proxies before the diagnosis of Alzheimer’s dementia.
The current coping skills of the participants were assessed repeatedly using Adaptive Behav‐
iour Scale - Residential and Community, Part I (Nihira et al. 1993). Earlier research supports
its feasibility in scientific studies of ageing and dementia in people with intellectual disabilities.
The clinical use of ABS to monitor ageing and dementia from the early non-symptomatic phase
to the advanced stages at various levels of abilities proved to be possible and helpful for the
clinician. A decline in ABS scores was seen in most participants after their early forties. This
supported the suspicion of Alzheimer’s disease, led to differential diagnostic assessments and
also helped in monitoring the progression of the disease.
Adaptive behaviour can be assessed by ABS in adults with intellectual disability at all phases
of ageing and dementia. This informant-based method overcame many of the problems of
cognitive based measures. For example, no cooperation or communication skills of the person
to be evaluated were needed for this assessment. Direct evaluations of cognitive functions were
not possible in this study due to the limited neuropsychological resources available. Stable
scores in clinically stable participants between repeated evaluations supported the reliability
of ABS, when used by proxy informants. The informants with a close and long familiarity to
their proxies observed and reported subtle changes in daily life and completed adaptive
behaviour questionnaires without obvious difficulty.
A careful evaluation of the life situation and comprehensive assessment of physical and mental
health is necessary when carers describe a decline in everyday functioning - that is a difficulty
in accomplishing daily tasks which the individual would normally complete with ease (Ball
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et al. 2006). This is also needed in the elderly with established Alzheimer’s disease because of
common co-morbidities. In the case of a rapid deterioration of function, the underlying reasons
should be assessed even when Alzheimer’s disease has been diagnosed and treatment started.
Visual acuity and hearing should be regularly monitored in all adults with Down syndrome
because of high prevalence’s of visual impairment and hearing loss. Alzheimer’s disease does
not protect from any other disease or disability. Other treatable conditions, including hypo‐
thyroidism, visual impairment and hearing loss, may be found.
The decline of the ABS total scores associated strongly to Alzheimer’s disease; therefore the
described declines in the ABS subscale scores probably reflect changes attributable to Alz‐
heimer’s disease. The relative rates of change among of the subscales of ABS differed. The
scores of the domains Domestic Activity, Responsibility, Self-Direction and Vocational
Activity declined more, as compared to other domains including Independent Functioning
and Physical Activities. This may reflect the early impairment of frontal lobe functions among
people with Down syndrome (Holland et al. 2000), including executive dysfunction in the
development of Alzheimer’s disease (Ball et al.2008).
Individual differences of the functional skills assessed by ABS scores were considerable.
Decline of skills with ageing started at very different ages among participants in this study.
The improvements of adaptive behaviour seen in several participants highlight the need for
careful assessment of treatable medical conditions and possibilities for supporting the
maintenance of functional independence. Stabilization of ABS scores was seen during medi‐
cation for Alzheimer’s disease in one participant for up to five years. Studies using population
based representative larger samples would be needed to further analyse factors that represent
potential confounders affecting adaptive behaviour more vigorously.
A considerable proportion of people with Down syndrome do not develop clinical dementia
at all (Coppus et al. 2006). People with Down syndrome differ in their individual biological
and genetic risk of dementia (Zigman & Lott 2007; Prasher et al. 2008; Patel et al. 2008). Better
understanding of genetic and environmental influences and medical conditions contributing
to these differences is needed.
Repeated prospective assessments overcome memory errors compared to retrospective
evaluations. Short questionnaires of adaptive behaviour change may be sufficient for screening
purposes (Prasher et al. 2004). However, repeated assessments are needed for the confirmation
of dementia and evaluation of interventions. The possibility of performing an assessment in
various settings without special professional expertise is a benefit of this approach.
The informant-based assessments of coping skills for daily living may prove practical and
useful for the follow up of ageing and dementia from the early non-symptomatic phase to the
advanced stages at various levels of abilities. The authors suggest repeated assessments of
adaptive behaviour and careful clinical evaluations to detect treatable medical conditions in
adults with Down syndrome.
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